Loading portfolio…

Sarepta Therapeutics, Inc. | Tormere

Sarepta Therapeutics, Inc.

Est. AUM

$0

13F long equity, this entity only

Positions

1

Period

Mar 2026 (Q1)

SEC EDGAR

View filings ↗

Mar 2026 (Q1)

#	Issuer	Class	Value	Shares	% Portfolio	Discretion
1	0	0	$0	—	0.00%	SOLE

Values in USD (reported in $thousands on 13F). Source: SEC EDGAR.